marketreports

Bicycle Component Market is forecast to reach $9.4 billion by 2025, growing at a CAGR 6.1% from 2020 to 2025. The global demand for bicycle components is directly correlated with the rapid industrialization and introduction of new, extremely light but very strong materials. That has transformed the bicycle component manufacturing industry. New technology and advanced methodology used to manufacture such bicycle components have been increasingly applied in the manufacturing sector of sports and mountain bicycles. In addition, there has been an increase in the number of participants involved in cycle sports, and their participation is expected to continue in the coming years. Increasing the number of international cycle racing events in emerging countries such as China, India, etc. is expected to drive growth over the forecast period in the global bicycle component market. Request Sample Report Coverage The report: “Bicycle Component Market – Forecast (2020-2025)”, by IndustryARC covers...

Allergy Treatment Market size is forecast to reach $28.71 billion by 2025, growing at a CAGR of 6.89% during the forecast period 2020-2025. Allergy is a condition in which the immune system reacts abnormally to a foreign substance. Increasing number of cases of allergic diseases like hay fever and anaphylaxis, increasing demand for non-prescribed OTC (over-the-counter) drugs for allergy treatment, and rapid growth of self-medication among consumers are major factors driving the growth of the market. Rising investment patterns in allergy drug development by the manufacturers and research and development of novel allergy immunotherapy (AIT) is expected to further enhance the overall Allergy Treatment Market demand during the forecast period 2020-2025. Allergy Treatment Industry Analysis is based on type, treatment, dosage, distribution channel and geography. Report Coverage The report: “Allergy Treatment Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the fol...

The Harvard University, while addressing the risk associated with reactions of new drugs prescription, has stated some overwhelming facts. According to their findings, even properly prescribed drugs causes about 1.9 million hospitalizations a year and about 128,000 people die from drugs prescribed to them.[1] Such epidemic condition is being tailgated by the need of safe and effective and specific use of the drug. Owing to such demands, companion diagnostic drug market is poised for exponential growth. Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients and is crucial for myriad of cancer and other therapies. Riding on the back of economic burden of global healthcare and with abundant potential to restrict the liability, companion diagnostic market size is estimated to be $2,950 million as of 2018. Request Sample Companion Diagnostic Market Outlook: Companion diagnostic (CDx) is a diagnostic test used as an...